Study: Local Anesthetics Could Improve Post-Traumatic Stress Disorder Symptoms
The study is a consolidation of published case reports and case series on the use of stellate ganglion block to treat patients who have tried conventional PTSD therapies without success. Twenty-four cases were examined by two independent evaluators.
The study found that 17 cases received one SGB and seven received multiple SGBs. Clinically-meaningful improvements were observed in 75 percent of cases after SGB. On average, PTSD improved by 50.4 percent for cases receiving one SGB and 69 percent for cases receiving multiple SGBs.
"Our article shows that SGB rapidly reduces chronic PTSD symptoms in patients treated across the country by Army, Navy, and civilian doctors alike. The growing evidence-base from multiple credible institutions caring for active duty service members, veterans and civilians who suffer from PTSD are consistent and impressive when examined in their totality," said Maryam Navaie, DrPH, president and CEO of Advance Health Solutions and lead study author.
More Articles on Anesthesia:MEDNAX Acquires Anesthesia and Pain Management Group
Anesthesiologist Compensation: 5 Points
Dr. Guy Cavaliere Joins AllCare Clinical Associates
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- How the 21st Century Cures Act impacts ASC physicians — 2 ASCA leaders shed insight
- 4 interventional spine pain procedures see 16%+ lower payment in 2017 — could the downward trend reverse next year?
- Total hip arthroplasty same-day vs. next-day discharge: 6 key findings
- 7 things for ASC leaders to know for Thursday — Feb. 23, 2017
- NAPA to present at 2017 AACD Perioperative Leadership Summit